Search

everythinglearnresearchcommunity

for

Search:↓

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Clascoterone 1% cream is a promising new treatment for acne.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Clascoterone may be an effective topical treatment for hair loss.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

ESR2 gene linked to female-pattern hair loss.

Caribine from traditional Chinese medicine may help treat hair loss.

Combination therapy is more effective for prostate volumes over 60 ml.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Paxillin may help manage androgen-related disorders like PCOS by stabilizing androgen receptor proteins.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Parsley contains compounds that might be good for treating hair loss.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Dobutamine does not mimic dopamine at therapeutic doses but may at very high concentrations; microfilaments, not microtubules, are important for wound healing in Xenopus embryos.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

Higher levels of the DP2 receptor may lead to hair loss.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

No clear link between specific gene and hair loss in Mexican brothers.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.